Semaglutide is a type of GLP-1 receptor agonist (GLP-1 RA), which can not only enhance insulin secretion, but also effectively inhibit glucagon secretion. It can help the pancreas release an appropriate amount of insulin to control blood sugar when blood sugar is high.
The main mechanism by which semaglutide can achieve blood sugar reduction and weight loss is that it can activate GLP-1 receptors, promote insulin secretion in a glucose concentration-dependent manner, inhibit glucagon secretion, delay gastric emptying and increase satiety, and inhibit appetite by inhibiting the action of the hypothalamic feeding center, thereby achieving the effect of blood sugar reduction and weight loss.
At the end of 2022, Tesla founder Musk was exposed to photos of himself after becoming fat, but then he lost weight crazily in just a few months and reappeared in front of the public with a healthy body. Musk replied to netizens on Twitter that his secret to achieving visible weight loss is regular fasting and Wegovy (i.e., Novo Nordisk's semaglutide injection for weight loss).
Therefore, we launched the GL Petid product. Its advantage is that it imitates the mechanism of semaglutide to achieve the effect of controlling sugar and reducing weight.
Are you interested in this product? Come and communicate with us in depth to learn more details!